$61.5 Million is the total value of Ayrton Capital LLC's 120 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
New | NORTHERN LIGHTS ACQUISITN CO | $12,524,000 | – | 1,180,376 | +100.0% | 20.35% | – | |
New | RELATIVITY ACQUISITION CORP | $2,014,000 | – | 200,000 | +100.0% | 3.27% | – | |
New | RINGCENTRAL INCnote 3/0 | $1,652,000 | – | 2,000,000 | +100.0% | 2.68% | – | |
New | WESTERN ACQSTN VENTURES CORP | $994,000 | – | 100,000 | +100.0% | 1.62% | – | |
New | GSR II METEORA ACQUISITN COR | $989,000 | – | 100,000 | +100.0% | 1.61% | – | |
New | ALSET CAPITAL ACQUISITION CO | $988,000 | – | 100,000 | +100.0% | 1.60% | – | |
New | CLOVER LEAF CAPITAL CORP | $760,000 | – | 75,000 | +100.0% | 1.24% | – | |
KERN | New | AKERNA CORP | $124,000 | – | 900,000 | +100.0% | 0.20% | – |
New | SHARPS TECHNOLOGY INC*w exp 04/13/202 | $65,000 | – | 235,200 | +100.0% | 0.11% | – | |
DOGZ | New | DOGNESS INTERNATIONAL CORP | $21,000 | – | 11,498 | +100.0% | 0.03% | – |
New | RELATIVITY ACQUISITION CORP*w exp 12/15/202 | $18,000 | – | 200,000 | +100.0% | 0.03% | – | |
New | COMERA LIFE SCIENCES HLDGS I*w exp 03/15/202 | $14,000 | – | 100,000 | +100.0% | 0.02% | – | |
New | CLARUS THERAPEUTICS HLDNGS I | $12,000 | – | 32,525 | +100.0% | 0.02% | – | |
New | WESTERN ACQSTN VENTURES CORP*w exp 09/01/202 | $12,000 | – | 100,000 | +100.0% | 0.02% | – | |
New | GSR II METEORA ACQUISITN COR*w exp 02/24/202 | $9,000 | – | 100,000 | +100.0% | 0.02% | – | |
New | ALSET CAPITAL ACQUISITION COright 01/31/2027 | $9,000 | – | 100,000 | +100.0% | 0.02% | – | |
New | CLOVER LEAF CAPITAL CORPright 05/31/2028 | $8,000 | – | 75,000 | +100.0% | 0.01% | – | |
New | ALSET CAPITAL ACQUISITION CO*w exp 01/31/202 | $4,000 | – | 50,000 | +100.0% | 0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
PHARMACYTE BIOTECH INC | 8 | Q3 2023 | 10.8% |
OCEANTECH ACQUISITIONS I COR | 8 | Q3 2023 | 5.2% |
STRAN & COMPANY INC | 8 | Q3 2023 | 0.2% |
NLS PHARMACEUTICS LTD | 8 | Q3 2023 | 0.1% |
FLAME ACQUISITION CORP | 8 | Q3 2023 | 0.3% |
ZIVO BIOSCIENCE INC | 8 | Q3 2023 | 0.2% |
WORKSPORT LTD | 8 | Q3 2023 | 0.1% |
HEARTBEAM INC | 8 | Q3 2023 | 0.1% |
OPPFI INC | 8 | Q3 2023 | 0.4% |
RELIANCE GLOBAL GROUP INC | 8 | Q3 2023 | 0.1% |
View Ayrton Capital LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
EUDA Health Holdings Ltd | February 14, 2023 | 995,725 | 4.9% |
MMTec, Inc. | February 14, 2023 | 91,228 | 2.9% |
SHF Holdings, Inc. | February 14, 2023 | 1,178,249 | 5.0% |
Northern Lights Acquisition Corp. | July 07, 2022 | 1,180,376 | 9.8% |
MMTec, Inc. | February 10, 2022 | 1,476,272 | 5.9% |
PepperLime Health Acquisition Corp | October 25, 2021 | 1,485,000 | 9.9% |
Toughbuilt Industries, Inc | July 22, 2021 | 6,904,488 | 5.3% |
TIAN RUIXIANG HOLDINGS LTD | June 14, 2021 | 666,667 | 5.7% |
Blue Hat Interactive Entertainment Technology | May 17, 2021 | 3,145,000 | 5.9% |
Cocrystal Pharma, Inc. | May 17, 2021 | 6,520,000 | 6.7% |
View Ayrton Capital LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13G/A | 2024-02-14 |
SC 13G | 2024-02-14 |
SC 13G | 2024-02-14 |
SC 13G | 2024-02-14 |
SC 13G | 2024-02-14 |
SC 13G | 2024-02-14 |
SC 13G | 2024-02-14 |
SC 13G | 2024-02-14 |
SC 13G | 2024-02-14 |
SC 13G | 2024-02-14 |
View Ayrton Capital LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.